Millennium Management
FHTX icon

Millennium Management’s Foghorn Therapeutics FHTX Stock Holding History

Millennium Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Sell
29,552
-179,013
-86% -$983K ﹤0.01% 5274
2025
Q4 		$1.13M Buy
208,565
+29,774
+17% +$135K ﹤0.01% 4401
2025
Q3 		$874K Buy
178,791
+160,197
+862% +$849K ﹤0.01% 4715
2025
Q2 		$87.4K Sell
18,594
-2,062
-10% -$8.62K ﹤0.01% 5530
2025
Q1 		$75.4K Sell
20,656
-71,984
-78% -$328K ﹤0.01% 5483
2024
Q4 		$437K Buy
92,640
+34,306
+59% +$250K ﹤0.01% 4846
2024
Q3 		$543K Buy
58,334
+36,380
+166% +$263K ﹤0.01% 4762
2024
Q2 		$126K Sell
21,954
-40,093
-65% -$239K ﹤0.01% 5263
2024
Q1 		$416K Buy
+62,047
New +$344K ﹤0.01% 4930
2023
Q2 		– Sell
-37,885
Closed -$235K – 6268
2023
Q1 		$235K Sell
37,885
-145,882
-79% -$955K ﹤0.01% 5076
2022
Q4 		$1.17M Buy
183,767
+53,266
+41% +$402K ﹤0.01% 4008
2022
Q3 		$1.12M Sell
130,501
-8,312
-6% -$107K ﹤0.01% 4239
2022
Q2 		$1.89M Sell
138,813
-23,505
-14% -$303K ﹤0.01% 3765
2022
Q1 		$2.47M Buy
162,318
+25,144
+18% +$345K ﹤0.01% 3674
2021
Q4 		$3.14M Buy
137,174
+44,541
+48% +$640K ﹤0.01% 3334
2021
Q3 		$1.29M Sell
92,633
-103,129
-53% -$1.14M ﹤0.01% 4404
2021
Q2 		$2.09M Buy
195,762
+33,644
+21% +$367K ﹤0.01% 3905
2021
Q1 		$2.14M Sell
162,118
-52,744
-25% -$864K ﹤0.01% 3471
2020
Q4 		$4.36M Buy
+214,862
New +$4.12M ﹤0.01% 2574

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Millennium Management's FHTX Position: Q1 2026 in Review

Millennium Management reduced its Foghorn Therapeutics (FHTX) stake by 86% in Q1 2026, selling an estimated $983K and leaving 29,552 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #5274.

Millennium Management first reported a position in FHTX in Q4 2020 and has held it in 19 quarters since. The position peaked at $4.36M in Q4 2020. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Millennium Management held 29,552 shares of Foghorn Therapeutics worth $141K as of Q1 2026.
  • Millennium Management sold 179,013 Foghorn Therapeutics shares in Q1 2026, an estimated $983K.
  • Foghorn Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5274 holding.
  • Millennium Management first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • Millennium Management's Foghorn Therapeutics position peaked at $4.36M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.